RecruitingNot ApplicableNCT06248333

Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy

Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel-group Trial

Sponsor

Xuanwu Hospital, Beijing

Enrollment

33 participants

Start Date

Feb 14, 2024

Study Type

INTERVENTIONAL

Conditions

Epilepsy, Drug Resistant

Summary

The primary objective of this research is to study the efficacy and safety of deep brain stimulation (DBS) of subthalamic nucleus (STN) as adjunctive therapy for reducing the frequency of seizures in drug-resistant focal motor epilepsy.

Eligibility

Min Age: 14 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called STN-DBS OFF and a medical device called STN-DBS ON for people with epilepsy, drug resistant. The study is currently recruiting participants at 1 location. People eligible for this study include aged 14 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESTN-DBS ON

Stimulation ON

DEVICESTN-DBS OFF

Stimulation OFF

Locations(1)

Xuanwu Hospital, Beijing

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06248333

Related Trials

Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)

NCT067197911 location